Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III L.P. | 13,760,200 8.700% | 5,984,440 (+76.96%) | Filing |
| 2023-12-28 4:17 pm Purchase | 2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III L.P. | 7,775,760 6.800% | 7,775,760 (New Position) | Filing |